Annual Revenue
$27.46 M
+$17.30 M+170.26%
31 December 2023
Summary:
Zevra Therapeutics annual revenue is currently $27.46 million, with the most recent change of +$17.30 million (+170.26%) on 31 December 2023. During the last 3 years, it has risen by +$14.17 million (+106.66%). ZVRA annual revenue is now -4.15% below its all-time high of $28.65 million, reached on 31 December 2021.ZVRA Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$3.69 M
-$754.00 K-16.95%
30 September 2024
Summary:
Zevra Therapeutics quarterly revenue is currently $3.69 million, with the most recent change of -$754.00 thousand (-16.95%) on 30 September 2024. Over the past year, it has increased by +$800.00 thousand (+27.63%). ZVRA quarterly revenue is now -71.40% below its all-time high of $12.92 million, reached on 31 December 2023.ZVRA Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$24.49 M
+$800.00 K+3.38%
30 September 2024
Summary:
Zevra Therapeutics TTM revenue is currently $24.49 million, with the most recent change of +$800.00 thousand (+3.38%) on 30 September 2024. Over the past year, it has increased by +$7.93 million (+47.85%). ZVRA TTM revenue is now -14.52% below its all-time high of $28.65 million, reached on 01 December 2021.ZVRA TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZVRA Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +170.3% | +27.6% | +47.9% |
| 3 y3 years | +106.7% | +88.0% | -13.9% |
| 5 y5 years | - | -67.8% | +113.6% |
ZVRA Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -4.2% | +170.3% | -71.4% | +184.2% | -14.5% | +161.3% |
| 5 y | 5 years | -4.2% | +170.3% | -71.4% | +184.2% | -14.5% | +161.3% |
| alltime | all time | -4.2% | +170.3% | -71.4% | +184.2% | -14.5% | +161.3% |
Zevra Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $3.69 M(-16.9%) | $24.49 M(+3.4%) |
| June 2024 | - | $4.45 M(+29.9%) | $23.69 M(-14.5%) |
| Mar 2024 | - | $3.42 M(-73.5%) | $27.71 M(+0.9%) |
| Dec 2023 | $27.46 M(+170.3%) | $12.92 M(+346.3%) | $27.46 M(+65.8%) |
| Sept 2023 | - | $2.90 M(-65.8%) | $16.56 M(+0.1%) |
| June 2023 | - | $8.47 M(+166.7%) | $16.54 M(+76.5%) |
| Mar 2023 | - | $3.18 M(+57.1%) | $9.37 M(-7.8%) |
| Dec 2022 | $10.16 M(-64.5%) | $2.02 M(-29.6%) | $10.16 M(-5.2%) |
| Sept 2022 | - | $2.87 M(+121.1%) | $10.72 M(+9.3%) |
| June 2022 | - | $1.30 M(-67.2%) | $9.81 M(-52.1%) |
| Mar 2022 | - | $3.96 M | $20.50 M |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $28.65 M(+115.6%) | - | - |
| Dec 2021 | - | $2.58 M(+31.4%) | $28.65 M(+0.8%) |
| Sept 2021 | - | $1.97 M(-83.6%) | $28.43 M(+0.1%) |
| June 2021 | - | $11.99 M(-1.1%) | $28.39 M(+21.8%) |
| Mar 2021 | - | $12.12 M(+412.1%) | $23.32 M(+75.5%) |
| Dec 2020 | $13.29 M(+3.5%) | $2.37 M(+22.9%) | $13.29 M(+8.1%) |
| Sept 2020 | - | $1.93 M(-72.1%) | $12.30 M(-43.7%) |
| June 2020 | - | $6.91 M(+230.7%) | $21.84 M(+46.3%) |
| Mar 2020 | - | $2.09 M(+51.8%) | $14.93 M(+16.3%) |
| Dec 2019 | $12.84 M | $1.38 M(-88.0%) | $12.84 M(+12.0%) |
| Sept 2019 | - | $11.46 M | $11.46 M |
FAQ
- What is Zevra Therapeutics annual revenue?
- What is the all time high annual revenue for Zevra Therapeutics?
- What is Zevra Therapeutics annual revenue year-on-year change?
- What is Zevra Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Zevra Therapeutics?
- What is Zevra Therapeutics quarterly revenue year-on-year change?
- What is Zevra Therapeutics TTM revenue?
- What is the all time high TTM revenue for Zevra Therapeutics?
- What is Zevra Therapeutics TTM revenue year-on-year change?
What is Zevra Therapeutics annual revenue?
The current annual revenue of ZVRA is $27.46 M
What is the all time high annual revenue for Zevra Therapeutics?
Zevra Therapeutics all-time high annual revenue is $28.65 M
What is Zevra Therapeutics annual revenue year-on-year change?
Over the past year, ZVRA annual revenue has changed by +$17.30 M (+170.26%)
What is Zevra Therapeutics quarterly revenue?
The current quarterly revenue of ZVRA is $3.69 M
What is the all time high quarterly revenue for Zevra Therapeutics?
Zevra Therapeutics all-time high quarterly revenue is $12.92 M
What is Zevra Therapeutics quarterly revenue year-on-year change?
Over the past year, ZVRA quarterly revenue has changed by +$800.00 K (+27.63%)
What is Zevra Therapeutics TTM revenue?
The current TTM revenue of ZVRA is $24.49 M
What is the all time high TTM revenue for Zevra Therapeutics?
Zevra Therapeutics all-time high TTM revenue is $28.65 M
What is Zevra Therapeutics TTM revenue year-on-year change?
Over the past year, ZVRA TTM revenue has changed by +$7.93 M (+47.85%)